Biocon Ltd will be selling its entire 78% stake in it's German unit, AxiCorp GmbH, to minority shareholders, for 40 million euros ($58.2 Mn).AxiCorp was the licensee for Biocon's insulin and Glargine products in Germany and had the sole responsibility for commercialising these products.
Transactio Reference: Business Standard
Religare Enterprises Limited will raise Rs.800 Cr through rights issue, with an option to increase the issue size by additional 10%.
Delhi based Yogya Enterprises is planning to raise R1.5 Cr by issuing 1 Mn equity shares at R15. The company plans to list itself on the SME platform.